Jul 2024 $3 M No. 6 $2 to $10 million 4
Diasome Pharmaceuticals LLC: Raise no. 6, Jul 2024 × Investors in this round 4 investors had bought by the notice of Aug 15, 2024: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $16 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $152,074
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert Geho · Executive Officer, Director W. Blair Geho · Executive Officer, Director Cosme Blair Ordonez · Director Frank Blair McCaney · Director Peter Blair Tollman · Director Thomas Blair McDonald · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert Geho, Chief Executive Officer. Newest notice filed Aug 15, 2024. Read the notice at the SEC .
equity, options SEC Jun 2023 $9 M No. 5 $2 to $10 million 2
Diasome Pharmaceuticals LLC: Raise no. 5, Jun 2023 × Investors in this round 2 investors had bought by the notice of Jun 30, 2023: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $15 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $349,999
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert Geho · Executive Officer, Director Frank Blair McCaney · Director Marc Blair Penn · Director Peter Blair Tollman · Director Thomas Blair McDonald · Director W. Blair Geho · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert Geho, Ceo. Newest notice filed Jun 30, 2023. Read the notice at the SEC .
equity SEC Aug 2022 $17 M No. 4 $10 to $50 million 40
Diasome Pharmaceuticals LLC: Raise no. 4, Aug 2022 × Investors in this round 40 investors had bought by the notice of Sep 8, 2022: 40 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $17 M of $19 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $537,746
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert Geho · Executive Officer, Director, Promoter Frank Blair McCaney · Director Marc Blair Penn · Director Thomas Blair McDonald · Director W. Blair Geho · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The Total Offering Amount and Total Amount Sold include convertible debt and the securities issuable hereto.”Signed by Robert Geho, Chief Executive Officer. Newest notice filed Sep 8, 2022. Read the notice at the SEC .
equity SEC Sep 2020 $2 M No. 3 Under $2 million 6
Diasome Pharmaceuticals LLC: Raise no. 3, Sep 2020 × Investors in this round 6 investors had bought by the notice of Dec 23, 2020: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert Geho · Executive Officer, Director, Promoter Frank Blair McCaney · Director Marc Blair Penn · Director Thomas Blair McDonald · Director W. Blair Geho · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert Geho, Chief Executive Officer. Newest notice filed Dec 23, 2020. Read the notice at the SEC .
debt, options SEC Mar 2020 $3 M No. 2 $2 to $10 million 20
Diasome Pharmaceuticals LLC: Raise no. 2, Mar 2020 × Investors in this round 20 investors had bought by the notice of Apr 1, 2020: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert Geho · Executive Officer, Director, Promoter Frank Blair McCaney · Director Marc Blair Penn · Director Thomas Blair McDonald · Director W. Blair Geho · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert Geho, Chief Executive Officer. Newest notice filed Apr 1, 2020. Read the notice at the SEC .
equity SEC Mar 2008 $13 M No. 1 $10 to $50 million 9
Diasome Pharmaceuticals LLC: Raise no. 1, Mar 2008 × Investors in this round 9 investors had bought by the notice of Apr 13, 2009: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $13 M offered; $1 M still to sell
Smallest investment taken $13,752
What was sold equity, debt
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Pa People named in the notice Len Rosenberg · Executive Officer, Director Robert Geho · Executive Officer W. Blair Geho · Executive Officer, Director Brenda Gavin · Director Devang Kantesaria · Director Richard Caruso · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Len Rosenberg, President. Newest notice filed Apr 13, 2009. Read the notice at the SEC .
equity, debt SEC